NCT06382610

Brief Summary

Melatonin is a hormone that promotes sleep that is available without a prescription in the United States. In addition to oral supplements, melatonin can be purchased in the form of lotions and bubble baths with unknown dosage and no frequency or age recommendations. In this study, researchers will examine how quickly melatonin in lotion and bubble bath is absorbed compared to oral tablets, as well as how long the melatonin lasts in the body.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
25 days until next milestone

Study Start

First participant enrolled

May 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

October 8, 2024

Status Verified

April 1, 2024

Enrollment Period

2 months

First QC Date

April 19, 2024

Last Update Submit

October 3, 2024

Conditions

Keywords

melatonintransdermaloralpharmacokinetics

Outcome Measures

Primary Outcomes (1)

  • Salivary melatonin level

    assessed via ELISA

    from immediately prior to administration to 48 hours post administration

Secondary Outcomes (1)

  • Side effects

    from immediately prior to administration to 48 hours post administration

Study Arms (3)

Oral tablet

ACTIVE COMPARATOR

3 mg Tablets (Nature Made). Participants will need to fast for 2 hours prior to consumption and 2 hours after consumption.

Dietary Supplement: Melatonin

Lotion

EXPERIMENTAL

Dr. Teal's Sleep Lotion with Melatonin, Lavender, and Chamomile. 3 g lotion applied to one arm (without washing for at least 4 hours).

Dietary Supplement: Melatonin

Bubble bath

EXPERIMENTAL

Dr. Teal's Sleep Bath with Melatonin, Lavender, and Chamomile. 40L warm tap water maintained between 36.5 - 40 degrees C (98 - 104 degrees F) and 2 ml bubble bath. Participants will soak their feet and legs in the cooler for 15 minutes and then dry off (without rinsing or washing for at least 4 hours).

Dietary Supplement: Melatonin

Interventions

MelatoninDIETARY_SUPPLEMENT

Melatonin will be administered in three different forms

Bubble bathLotionOral tablet

Eligibility Criteria

Age18 Years - 22 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • University of Redlands student

You may not qualify if:

  • Allergies or sensitivities to scented lotions or bath products
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Redlands

Redlands, California, 92373, United States

Location

MeSH Terms

Interventions

Melatonin

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Lisa E Olson, Ph.D.

    University of Redlands

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Repeated measures crossover trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2024

First Posted

April 24, 2024

Study Start

May 19, 2024

Primary Completion

July 31, 2024

Study Completion

July 31, 2024

Last Updated

October 8, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Upload salivary melatonin levels and side effect frequencies (all collected IPD) to National Sleep Research Resource (https://sleepdata.org/)

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After relevant publication. Data will remain at the National Sleep Research Resource following their policy for keeping records.
Access Criteria
According to the National Sleep Research Resource

Locations